Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ANI Pharmaceuticals (ANIP) one of those stocks right now? A ...

Truist analyst Les Sulewski raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $65 from $62 and keeps a Hold rating on the shares ...

During the last three months, 6 analysts shared their evaluations of ANI Pharmaceuticals (NASDAQ:ANIP), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

ANI Pharmaceuticals has a 12 month low of $52.50 and a 12 month high of $70.00. The stock has a market capitalization of $1.44 billion, a P/E ratio of -120.02 and a beta of 0.49.

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

April 9 (UPI) --Pharmaceuticals produced in China could become costlier after President Donald Trump announced his intention to impose a "major tariff on pharmaceuticals." Trump said he would ...

US President Donald Trump, on Wednesday, said his administration would soon announce a “major” tariff on pharmaceutical imports, aimed at encouraging drug manufacturers to shift operations ...

President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the ...